Travere Therapeutics (TVTX) Superinvestor holders
15 of the superinvestors we track hold Travere Therapeutics (TVTX) in their latest 13F filings, $488M in total.
Summary
The largest holder is Jim Simons (Renaissance Technologies), with $104M, 0.1% of the portfolio.
In their latest quarter: 4 opened a new position, 5 added, 6 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Jim Simons Renaissance Technologies |
Trimmed | 1,833,079 | $104M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 1,565,656 | $89M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 1,440,469 | $82M | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 1,333,207 | $76M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 591,815 | $34M | 0.1% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 478,860 | $27M | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 470,914 | $27M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
New position | 446,696 | $25M | 1.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 270,048 | $15M | 0.0% | Q2 2026 |
| Arrowstreet Capital | New position | 55,037 | $3M | 0.0% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
New position | 34,315 | $2M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 27,628 | $2M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 18,999 | $1M | 0.0% | Q3 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 14,247 | $838,884 | 0.0% | Q3 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 5,955 | $338,304 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 15 |
| Q1 2026 | 16 |
| Q4 2025 | 19 |
| Q3 2025 | 19 |
| Q2 2025 | 16 |
| Q1 2025 | 14 |
| Q4 2024 | 13 |
| Q3 2024 | 12 |
Questions about Travere Therapeutics
Which superinvestors own Travere Therapeutics?
15 of the superinvestors we track hold Travere Therapeutics (TVTX) in their latest 13F filings, $488M in total. Jim Simons, Two Sigma, David Shaw, Paul Marshall, Ensign Peak, Steve Cohen.
Who is the largest superinvestor holder of TVTX?
The largest holder is Jim Simons (Renaissance Technologies), with $104M, 0.1% of the portfolio.
From Travere Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.